A consultant Public Health Physician at Ikorodu General Hospital, Dr Yetunde Odusolu has called for an urgent action to prevent hepatitis, ...

The genetically modified animal model could lead to new treatments for the global disease Lauren Rust, Ph.D., assistant staff ...

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...

Fresh and frozen berries grown in other countries have been a common source of hepatitis A and norovirus outbreaks in the U.S ...

After more than a decade leading the MRC-University of Glasgow Centre for Virus Research (CVR), Professor Massimo Palmarini ...

The UK government has announced that it is renewing funding for the public health campaign HIV Prevention England for another year as part of efforts to end HIV transmission by 2030. The programme, ...

Proceeds expected to fund the start of the ALG-000184 Phase 2 clinical studyFunding expected to extend cash runway into the second half of ...

Aligos Therapeutics (ALGS) has entered into a securities purchase agreement for a private placement that is expected to result in gross ...

SOUTH SAN FRANCISCO - Aligos Therapeutics, Inc. (NASDAQ:ALGS), a company specializing in therapies for liver and viral diseases with a current market capitalization of $96.58 million, announced today ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024. "Gilead delivered another exceptionally ...